Сортировать:
- по релевантности
- по дате
- по зарплате
... Saudi Arabia, and the UAE. R-Pharm Holding generates over $2 billion in revenue and employs more than 5,000 staff. Olokizumab is the first interleukin-6 (IL-6) inhibitor approved for treatment of rheumatoid arthritis which blocks directly cytokine instead ...
25.12.2025